Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes

NCT01203592 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01203592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01203592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2010
Completion date
August 31, 2013
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital myasthenic syndrome